Brand Name | Status | Last Update |
---|---|---|
febuxostat | ANDA | 2025-01-10 |
uloric | New Drug Application | 2023-04-27 |
Indication | Ontology | MeSH | ICD-10 |
---|---|---|---|
gout | EFO_0004274 | D006073 | M10 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Gout | D006073 | EFO_0004274 | M10 | 6 | 16 | 13 | 10 | 9 | 52 |
Hyperuricemia | D033461 | — | — | 3 | 14 | 4 | 8 | 10 | 38 |
Chronic renal insufficiency | D051436 | — | N18 | — | — | — | 3 | 4 | 7 |
Hypertension | D006973 | EFO_0000537 | I10 | — | 1 | — | 3 | 1 | 5 |
Cardiovascular diseases | D002318 | EFO_0000319 | I98 | — | — | 1 | 1 | 1 | 3 |
Non-alcoholic fatty liver disease | D065626 | EFO_0003095 | K75.81 | — | 2 | — | 1 | — | 3 |
Diabetic nephropathies | D003928 | EFO_0000401 | — | — | — | — | 1 | 1 | 2 |
Diabetes mellitus | D003920 | EFO_0000400 | E08-E13 | — | — | — | 1 | 1 | 2 |
Liver diseases | D008107 | EFO_0001421 | K70-K77 | — | 1 | — | 1 | — | 2 |
Fatty liver | D005234 | EFO_0003934 | — | — | 1 | — | 1 | — | 2 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Hematologic neoplasms | D019337 | — | — | 1 | 1 | 1 | — | — | 2 |
Tumor lysis syndrome | D015275 | — | E88.3 | 1 | 1 | 1 | — | — | 2 |
Syndrome | D013577 | — | — | — | — | 1 | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Renal insufficiency | D051437 | — | N19 | — | 2 | — | — | — | 2 |
Asymptomatic diseases | D058070 | — | — | 1 | 2 | — | — | — | 2 |
Albuminuria | D000419 | EFO_0004285 | R80.9 | — | 1 | — | — | — | 1 |
Type 2 diabetes mellitus | D003924 | EFO_0001360 | E11 | — | 1 | — | — | — | 1 |
Gouty arthritis | D015210 | — | — | — | 1 | — | — | — | 1 |
Angina pectoris | D000787 | EFO_0003913 | I20 | — | 1 | — | — | — | 1 |
Joint diseases | D007592 | — | M12.9 | — | 1 | — | — | — | 1 |
Alcoholic fatty liver | D005235 | — | K70.0 | — | 1 | — | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Healthy volunteers/patients | — | — | — | 5 | — | — | — | — | 5 |
Therapeutic equivalency | D013810 | — | — | 1 | — | — | — | — | 1 |
Drug interactions | D004347 | — | — | 1 | — | — | — | — | 1 |
Ulcerative colitis | D003093 | EFO_0000729 | K51 | 1 | — | — | — | — | 1 |
Colitis | D003092 | EFO_0003872 | K52.9 | 1 | — | — | — | — | 1 |
Ulcer | D014456 | MPATH_579 | — | 1 | — | — | — | — | 1 |
Carotid intima-media thickness | D059168 | — | — | 1 | — | — | — | — | 1 |
Parkinson disease | D010300 | EFO_0002508 | G20 | 1 | — | — | — | — | 1 |
Autosomal dominant polycystic kidney | D016891 | EFO_1001496 | Q61.2 | 1 | — | — | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Oxidative stress | D018384 | EFO_1001905 | — | — | — | — | — | 1 | 1 |
Rheumatic fever | D012213 | EFO_1001160 | I00-I02 | — | — | — | — | 1 | 1 |
Patient compliance | D010349 | — | — | — | — | — | — | 1 | 1 |
Urinary calculi | D014545 | — | N20.9 | — | — | — | — | 1 | 1 |
Blood pressure | D001794 | EFO_0004325 | — | — | — | — | — | 1 | 1 |
Inflammation | D007249 | MP_0001845 | — | — | — | — | — | 1 | 1 |
Drug common name | Febuxostat |
INN | febuxostat |
Description | Febuxostat is a 1,3-thiazolemonocarboxylic acid that is 4-methyl-1,3-thiazole-5-carboxylic acid which is substituted by a 3-cyano-4-(2-methylpropoxy)phenyl group at position 2. It is an orally-active, potent, and selective xanthine oxidase inhibitor used for the treatment of chronic hyperuricaemia in patients with gout. It has a role as an EC 1.17.3.2 (xanthine oxidase) inhibitor. It is an aromatic ether, a nitrile and a 1,3-thiazolemonocarboxylic acid. |
Classification | Small molecule |
Drug class | enzyme inhibitors: xanthine oxidase/dehydrogenase inhibitors |
Image (chem structure or protein) | ![]() |
Structure (InChI/SMILES or Protein Sequence) | Cc1nc(-c2ccc(OCC(C)C)c(C#N)c2)sc1C(=O)O |
PDB | — |
CAS-ID | 144060-53-7 |
RxCUI | — |
ChEMBL ID | CHEMBL1164729 |
ChEBI ID | — |
PubChem CID | 134018 |
DrugBank | DB04854 |
UNII ID | 101V0R1N2E (ChemIDplus, GSRS) |